ADR120S, Inc. (3750)

Market cap
¥7.3B
P/E ratio
102.2x
Saitori Cell Research Institute develops regenerative cell therapies and medical devices while also investing in real estate projects through seven subsidiaries.
Period EndProperty, plant and equipment, net (Million JPY)YoY (%)
Mar 31, 20252,960-29.81%
Mar 31, 20244,218-64.04%
Mar 31, 202311,727-2.61%
Mar 31, 202212,041+61.27%
Mar 31, 20217,467-2.55%
Mar 31, 20207,662+139031.00%
Mar 31, 20196-99.75%
Mar 31, 20182,218+37151.46%
Mar 31, 20176-47.12%
Mar 31, 201611-93.32%
Mar 31, 2015168
AI Chat